Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography

Ryan Matsuda, So Hwang Kye, Jeanethe Anguizola, David S Hage

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Diabetes is a health condition associated with the elevated levels of glucose in the bloodstream and affects 366 million people worldwide. Type II diabetes is often treated with sulfonylurea drugs, which are known to bind tightly in the blood to the transport protein human serum albumin (HSA). One consequence of the elevated levels of glucose in diabetes is the nonenzymatic glycation of proteins such as HSA. Several areas of HSA are now known to be affected by glycation-related modifications, which may in turn affect the binding of sulfonylurea drugs and other solutes to this protein. This review discusses some recent studies that have examined these changes in drug-protein binding by employing high-performance affinity chromatography (HPAC). A description of the theoretical and experimental techniques that were used in these studies is given. The information on drug interactions with glycated HSA, as obtained through this method, is also summarized. In addition, the potential advantages of this approach in the areas of biointeraction analysis and personalized medicine are considered.

Original languageEnglish (US)
Pages (from-to)79-94
Number of pages16
JournalReviews in Analytical Chemistry
Volume33
Issue number2
DOIs
StatePublished - Aug 1 2014

Fingerprint

Drug interactions
Affinity chromatography
Serum Albumin
Medical problems
Pharmaceutical Preparations
Glucose
Medicine
Carrier Proteins
Proteins
Blood
Health

Keywords

  • Binding studies
  • Diabetes
  • Drug-protein binding
  • Glycation
  • High-performance affinity chromatography
  • Human serum albumin
  • Sulfonylurea drugs

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography. / Matsuda, Ryan; Kye, So Hwang; Anguizola, Jeanethe; Hage, David S.

In: Reviews in Analytical Chemistry, Vol. 33, No. 2, 01.08.2014, p. 79-94.

Research output: Contribution to journalArticle

@article{0e1bef862a394b9689ad34d056032613,
title = "Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography",
abstract = "Diabetes is a health condition associated with the elevated levels of glucose in the bloodstream and affects 366 million people worldwide. Type II diabetes is often treated with sulfonylurea drugs, which are known to bind tightly in the blood to the transport protein human serum albumin (HSA). One consequence of the elevated levels of glucose in diabetes is the nonenzymatic glycation of proteins such as HSA. Several areas of HSA are now known to be affected by glycation-related modifications, which may in turn affect the binding of sulfonylurea drugs and other solutes to this protein. This review discusses some recent studies that have examined these changes in drug-protein binding by employing high-performance affinity chromatography (HPAC). A description of the theoretical and experimental techniques that were used in these studies is given. The information on drug interactions with glycated HSA, as obtained through this method, is also summarized. In addition, the potential advantages of this approach in the areas of biointeraction analysis and personalized medicine are considered.",
keywords = "Binding studies, Diabetes, Drug-protein binding, Glycation, High-performance affinity chromatography, Human serum albumin, Sulfonylurea drugs",
author = "Ryan Matsuda and Kye, {So Hwang} and Jeanethe Anguizola and Hage, {David S}",
year = "2014",
month = "8",
day = "1",
doi = "10.1515/revac-2013-0029",
language = "English (US)",
volume = "33",
pages = "79--94",
journal = "Reviews in Analytical Chemistry",
issn = "0793-0135",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "2",

}

TY - JOUR

T1 - Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography

AU - Matsuda, Ryan

AU - Kye, So Hwang

AU - Anguizola, Jeanethe

AU - Hage, David S

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Diabetes is a health condition associated with the elevated levels of glucose in the bloodstream and affects 366 million people worldwide. Type II diabetes is often treated with sulfonylurea drugs, which are known to bind tightly in the blood to the transport protein human serum albumin (HSA). One consequence of the elevated levels of glucose in diabetes is the nonenzymatic glycation of proteins such as HSA. Several areas of HSA are now known to be affected by glycation-related modifications, which may in turn affect the binding of sulfonylurea drugs and other solutes to this protein. This review discusses some recent studies that have examined these changes in drug-protein binding by employing high-performance affinity chromatography (HPAC). A description of the theoretical and experimental techniques that were used in these studies is given. The information on drug interactions with glycated HSA, as obtained through this method, is also summarized. In addition, the potential advantages of this approach in the areas of biointeraction analysis and personalized medicine are considered.

AB - Diabetes is a health condition associated with the elevated levels of glucose in the bloodstream and affects 366 million people worldwide. Type II diabetes is often treated with sulfonylurea drugs, which are known to bind tightly in the blood to the transport protein human serum albumin (HSA). One consequence of the elevated levels of glucose in diabetes is the nonenzymatic glycation of proteins such as HSA. Several areas of HSA are now known to be affected by glycation-related modifications, which may in turn affect the binding of sulfonylurea drugs and other solutes to this protein. This review discusses some recent studies that have examined these changes in drug-protein binding by employing high-performance affinity chromatography (HPAC). A description of the theoretical and experimental techniques that were used in these studies is given. The information on drug interactions with glycated HSA, as obtained through this method, is also summarized. In addition, the potential advantages of this approach in the areas of biointeraction analysis and personalized medicine are considered.

KW - Binding studies

KW - Diabetes

KW - Drug-protein binding

KW - Glycation

KW - High-performance affinity chromatography

KW - Human serum albumin

KW - Sulfonylurea drugs

UR - http://www.scopus.com/inward/record.url?scp=84924534662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924534662&partnerID=8YFLogxK

U2 - 10.1515/revac-2013-0029

DO - 10.1515/revac-2013-0029

M3 - Article

VL - 33

SP - 79

EP - 94

JO - Reviews in Analytical Chemistry

JF - Reviews in Analytical Chemistry

SN - 0793-0135

IS - 2

ER -